🧬 SSTR1 (Somatostatin Receptor 1)

neuropeptide receptor sstr1 somatostatin glioblastoma

SSTR1 is one of five G-protein-coupled somatostatin receptors involved in neurotransmission, hormone regulation, and tumor biology.

🔹 1. Gene and Expression

  • Gene: SSTR1
  • Location: Chromosome 14q13
  • Expression:
    • Brain (especially cortex, hippocampus)
    • Pancreas, GI tract, pituitary
    • Downregulated in glioblastoma

🔹 2. Function

  • Gi/o-coupled receptor → ↓cAMP
  • Inhibits hormone secretion (e.g., GH, insulin)
  • CNS: modulates synaptic activity, neuroprotection
  • Antiproliferative and antiangiogenic effects

🔹 3. Clinical Relevance

  • SSTR1 in glioblastoma = poor prognosis
  • Correlates with:
    • IDH1-wildtype
    • EGFR amplification
    • G-CIMP-negative subtype
  • May serve as a prognostic biomarker

💊 4. Therapeutic Implications

  • Agonists: octreotide, pasireotide
    • ↓ proliferation in GBM cell lines
  • Potential strategies:
    • Targeted therapy with SSTR1 agonists
    • Combined molecular profiling + treatment

🔬 5. Ligands and Pathways

Type Example Function
Agonist Octreotide ↓ tumor cell growth
Agonist Pasireotide Broader affinity (SSTR1/2/5)
Antagonist (under study) Not clinically available

Signaling Pathways Affected:

  • ↓ Adenylyl cyclase → ↓ cAMP
  • CDKN1A-B upregulation
  • Modulation of JAK/STAT, NF-κB, TGF-β pathways

—- 📄 G-García et al. (2025) – Full article

  • sstr1.txt
  • Last modified: 2025/04/25 09:23
  • by 127.0.0.1